News
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics SparingVision remains focused on in vivo genomic medicines, with SPVN20, a GIRK-based gene therapy candidate, expected to reach ...
Review Article Published: 14 April 2010 Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease Christian Lüscher & Paul A. Slesinger Nature Reviews ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback